Y. Takita

发表

Long‐term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder

P. Trzepacz, A. Allen, Yuko Hirata, 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention‐deficit hyperactivity disorder

T. Treuer, Dongwon Shin, G. Bahn, 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Nasal glucagon as a viable alternative for treating insulin‐induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study

M. Matsuhisa, Y. Nagai, H. Nagashima, 2020, Diabetes, obesity & metabolism.

Efficacy and safety of tabalumab plus standard of care in Japanese patients with active systemic lupus erythematosus: Subgroup analyses of the ILLUMINATE-1 study

Yoshiya Tanaka, T. Takeuchi, Y. Takita, 2017, Modern rheumatology.

Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo‐controlled clinical studies

M. Oelke, L. Viktrup, A. Wagg, 2017, BJU international.

Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide is non‐inferior to once‐daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26‐week randomized phase III study

T. Takamura, T. Imaoka, M. Odawara, 2015, Diabetes, obesity & metabolism.

A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder.

T. Koeda, A. Allen, K. Yamazaki, 2009, Journal of child and adolescent psychopharmacology.

Open‐label, dose‐titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention‐deficit/hyperactivity disorder

S. Gau, Sang-Keun Chung, T. Goto, 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

An open‐label, dose‐titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention‐deficit/hyperactivity disorder

H. Matsumoto, H. Ichikawa, T. Goto, 2011, Psychiatry and clinical neurosciences.

Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD

P. Trzepacz, S. Gau, D. Song, 2017, Journal of attention disorders.

Imaging characteristics and safety of florbetapir (18F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer’s disease

A. Joshi, M. Pontecorvo, M. Senda, 2015, Annals of Nuclear Medicine.

Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once‐daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study

T. Takamura, T. Imaoka, M. Odawara, 2016, Diabetes, obesity & metabolism.

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)

T. Ishii, R. Nishikomori, N. Kanazawa, 2023, Pediatric Rheumatology.

Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials

Y. Isaka, N. Katoh, H. Torisu-Itakura, 2022, Dermatology and Therapy.

Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.

M. Tohen, S. Kanba, T. Higuchi, 2012, Journal of affective disorders.

Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder

M. Tohen, S. Kanba, T. Higuchi, 2012, Current medical research and opinion.

Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site

R. Nishimura, T. Aranishi, Y. Nagai, 2019, Diabetes Therapy.

Safety and efficacy of the combination of once‐daily tadalafil and alpha‐1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo‐controlled, cross‐over study

M. Takeda, O. Yokoyama, O. Nishizawa, 2017, International journal of urology : official journal of the Japanese Urological Association.

Long-Term, Open-Label, Safety Study of Edivoxetine as Adjunctive Treatment for Adult Patients with Major Depressive Disorder Who Were Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment in Japan

C. Goldberger, E. Monkul, M. Bangs, 2015 .

Efficacy and Safety of Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib Administered as Monotherapy in Japanese Patients With Primary Hypercholesterolemia.

A. Kiyosue, T. Teramoto, J. Riesmeyer, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Efficacy and Safety of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia.

A. Kiyosue, T. Teramoto, J. Riesmeyer, 2017, Circulation journal : official journal of the Japanese Circulation Society.